Exclusive

Publication

Byline

The wind has caught the sails of broader markets, but beware of choppiness

New Delhi, Sept. 20 -- Small-caps shot up much more than the front-line indices last week, and investors may be taking more risks here. After the change in rules regarding multi-cap fund allocations, ... Read More


Dr Reddy's US earnings to get a boost, but valuations are pricey

New Delhi, Sept. 18 -- Dr Reddy's Laboratories Ltd's settlement with Celgene, a subsidiary of Bristol Meyers Squibb, regarding the Revlimid patent will open up opportunities in the US market, post-FY2... Read More


Dr Reddy's Revlimid settlement to boost US earnings beyond FY23

New Delhi, Sept. 18 -- Dr Reddy's Laboratories' settlement with Celgene on Revlimid patents is a positive, and will open up opportunities in the US market, post-FY23. After several favourable rulings ... Read More


Dixon's domestic thrust drive stock past Havells

New Delhi, Sept. 18 -- The government's fillip to manufacturing in India has heightened the buzz around contract manufacturers such as Dixon Technologies Ltd. Its shares have been sprinting, gaining n... Read More


Buffett's Japan bet is a 'clear arbitrage' that cuts currency risks

New Delhi, Sept. 18 -- Warren Buffett is known to have a penchant for low-valuation, high-yield investments. In the past, the Sage of Omaha had invested in railway stocks when they were inexpensively ... Read More


Small caps rise after tweaks by Sebi, but rally may not sustain

New Delhi, Sept. 18 -- A circular on 11 September by the Securities and Exchange Board of India (Sebi) dictating asset allocation framework for multicap funds has fired up small stocks. The Nifty Smal... Read More


Following KKR's acquisition, JB Chemicals stock has taken wing

New Delhi, Sept. 17 -- Private-equity firm KKR's purchase of a stake in JB Chemicals and Pharmaceuticals Ltd has done a lot of good for the latter's stock. Ever since the acquisition was announced, it... Read More


Post KKR's acquisition, JB Chemicals stock has taken wings

New Delhi, Sept. 17 -- Private-equity firm KKR's purchase of a stake in JB Chemicals and Pharmaceuticals Ltd has done a lot of good for the latter's stock. Ever since the acquisition, its stock has ju... Read More


Post KKR's acquisition, JB Chemicals stock takes wings

New Delhi, Sept. 17 -- Private-equity firm KKR's purchase of a stake in JB Chemicals and Pharmaceuticals Ltd has boosted the company's stock, which jumped 51% since the acquisition. The recently annou... Read More


Apollo Hospitals' recovery from covid is encouraging, but its stock is pricey

New Delhi, Sept. 16 -- Hospital chains have been hit by the covid-19 pandemic, and Apollo Hospitals Enterprises Ltd's revenues growth contraction is no surprise. But the firm did well to pull up its s... Read More